Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
sIPV in healthy infants
NCT07297186Phase 3Completed
- Sponsor
- Beijing Minhai Biological
- Start
- Aug 2017
- Primary completion
- Apr 2023
- Modality
- Recombinant Proteins and Enzymes, Vaccines & Immunotherapeutics
- Countries
- 1
01
Overview
A Phase 3 trial of sabin-strain inactivated poliovirus vaccine (vero cell) in poliomyelitis, sponsored by Beijing Minhai Biological. Started Aug 2017; status: completed.
02
Drugs
sabin-strain inactivated poliovirus vaccine (vero cell)
03
Conditions
poliomyelitis
Beyond the preview
Go deeper on NCT07297186.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07297186.